Showing results (1-10 of 6) with videos related to
Sort By:
Pageof 1
Molecular & Cellular Proteomics : MCP|April 13, 2010
Plasma membrane proteomics and its application in clinical cancer biomarker discoveryRikke Leth-Larsen, Rikke R Lund, Henrik J DitzelCancer Genomics & Proteomics|September 20, 2012
Identification of markers associated with highly aggressive metastatic phenotypes using quantitative comparative proteomicsMikkel G Terp, Rikke R Lund, Ole N Jensen, et al.Journal of Immunology (Baltimore, Md. : 1950)|September 18, 2013
Anti-human CD73 monoclonal antibody inhibits metastasis formation in human breast cancer by inducing clustering and internalization of CD73 expressed on the surface of cancer cellsMikkel G Terp, Kristina A Olesen, Eva C Arnspang, et al.Biotechnology Progress|February 23, 2020
A novel approach to evaluate ELISA antibody coverage of host cell proteins-combining ELISA-based immunocapture and mass spectrometryKatrine Pilely, Solveig B Nielsen, Anette Draborg, et al.Molecular & Cellular Proteomics : MCP|September 10, 2015
NADH-Cytochrome b5 Reductase 3 Promotes Colonization and Metastasis Formation and Is a Prognostic Marker of Disease-Free and Overall Survival in Estrogen Receptor-Negative Breast CancerRikke R Lund, Rikke Leth-Larsen, Tina Di Caterino, et al.Oncotarget|August 29, 2015
miR-155, identified as anti-metastatic by global miRNA profiling of a metastasis model, inhibits cancer cell extravasation and colonization in vivo and causes significant signaling alterationsKarina G Thomsen, Mikkel G Terp, Rikke R Lund, et al.Pageof 1